T1	Participants 500 662	7,280 men underwent a PSA-determination and DRE of whom 2,102 underwent prostate biopsy (biopsy indication PSA > or = 4.0 ng/ml and/or suspicious DRE and/or TRUS)
T2	Participants 1050 1102	2,102 men biopsied, 443 PCs were detected (PPV = 21%
